Corbus Pharmaceuticals Holdings SG&A Expense (Quarterly) Analysis

Corbus Pharmaceuticals Holdings Inc (CRBP)

38.77 +0.57 (+1.49%) USD | NASDAQ | May 03, 16:00

38.81 +0.04 (+0.10%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	3.123M
September 30, 2023	2.937M
June 30, 2023	3.940M
March 31, 2023	3.909M
December 31, 2022	4.554M
September 30, 2022	4.073M
June 30, 2022	4.840M
March 31, 2022	5.231M
December 31, 2021	4.235M
September 30, 2021	5.277M
June 30, 2021	5.572M
March 31, 2021	5.341M
December 31, 2020	5.360M
September 30, 2020	7.682M
June 30, 2020	7.739M
March 31, 2020	7.700M
December 31, 2019	6.276M
September 30, 2019	5.534M
June 30, 2019	5.208M
March 31, 2019	6.625M
December 31, 2018	3.737M

Date	Value
September 30, 2018	3.181M
June 30, 2018	2.988M
March 31, 2018	3.05M
December 31, 2017	2.575M
September 30, 2017	2.131M
June 30, 2017	1.878M
March 31, 2017	2.380M
December 31, 2016	2.568M
September 30, 2016	1.761M
June 30, 2016	1.021M
March 31, 2016	1.110M
December 31, 2015	1.042M
September 30, 2015	0.7906M
June 30, 2015	0.9691M
March 31, 2015	0.8119M
December 31, 2014	0.6875M
September 30, 2014	0.3656M
June 30, 2014	0.2949M
March 31, 2014	0.0437M
December 31, 2013	0.2915M
September 30, 2013	0.0164M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

2.937M

Minimum

Sep 2023

7.739M

Maximum

Jun 2020

5.186M

Average

5.231M

Median

Mar 2022

SG&A Expense (Quarterly) Benchmarks